Literature DB >> 14995902

Genetic defects in the oxidative phosphorylation (OXPHOS) system.

Rolf J R J Janssen1, Lambert P van den Heuvel, Jan A M Smeitink.   

Abstract

The oxidative phosphorylation (OXPHOS) system consists of five multiprotein complexes and two mobile electron carriers embedded in the lipid bilayer of the mitochondrial inner membrane. With the exception of complex II and the mobile carriers, the other parts of the OXPHOS system are under dual genetic control. Due to this bigenomic control, the inheritance of OXPHOS system defects is either maternal, in the case of mitochondrial DNA mutations, autosomal or X-linked, in the case of nuclear gene defects. In this review, our current genetic understanding of OXPHOS system enzyme deficiencies will be summarized, and future directions that the field might take to unravel so-far genetically unresolved OXPHOS system enzyme deficiencies will be described, with special emphasis on complex I biogenesis. Copyright Future Drugs Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14995902     DOI: 10.1586/14737159.4.2.143

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  13 in total

1.  Complements of the house.

Authors:  Eric A Schon
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

2.  Mutations in the ND5 subunit of complex I of the mitochondrial DNA are a frequent cause of oxidative phosphorylation disease.

Authors:  M J Blok; L Spruijt; I F M de Coo; K Schoonderwoerd; A Hendrickx; H J Smeets
Journal:  J Med Genet       Date:  2007-04       Impact factor: 6.318

3.  Atrophic gastritis: deficient complex I of the respiratory chain in the mitochondria of corpus mucosal cells.

Authors:  Marju Gruno; Nadezhda Peet; Andres Tein; Riina Salupere; Meeli Sirotkina; Julio Valle; Ants Peetsalu; Enn K Seppet
Journal:  J Gastroenterol       Date:  2008-10-29       Impact factor: 7.527

4.  Transcriptional Regulation of SDHa flavoprotein by nuclear respiratory factor-1 prevents pseudo-hypoxia in aerobic cardiac cells.

Authors:  Claude A Piantadosi; Hagir B Suliman
Journal:  J Biol Chem       Date:  2008-02-05       Impact factor: 5.157

Review 5.  Mouse models for nuclear DNA-encoded mitochondrial complex I deficiency.

Authors:  Saskia Koene; Peter H G M Willems; Peggy Roestenberg; Werner J H Koopman; Jan A M Smeitink
Journal:  J Inherit Metab Dis       Date:  2010-01-27       Impact factor: 4.982

6.  Xenotransplantation of mitochondrial electron transfer enzyme, Ndi1, in myocardial reperfusion injury.

Authors:  Cynthia N Perry; Chengqun Huang; Wayne Liu; Najib Magee; Raquel Sousa Carreira; Roberta A Gottlieb
Journal:  PLoS One       Date:  2011-02-14       Impact factor: 3.240

7.  No immune responses by the expression of the yeast Ndi1 protein in rats.

Authors:  Mathieu Marella; Byoung Boo Seo; Terence R Flotte; Akemi Matsuno-Yagi; Takao Yagi
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

8.  Mitochondrial proteomics on human fibroblasts for identification of metabolic imbalance and cellular stress.

Authors:  Johan Palmfeldt; Søren Vang; Vibeke Stenbroen; Christina B Pedersen; Jane H Christensen; Peter Bross; Niels Gregersen
Journal:  Proteome Sci       Date:  2009-05-28       Impact factor: 2.480

9.  Analysis of mitochondrial DNA sequences in childhood encephalomyopathies reveals new disease-associated variants.

Authors:  Aijaz A Wani; Sajad H Ahanger; Sharmila A Bapat; Ashraf Y Rangrez; Nitin Hingankar; C G Suresh; Shama Barnabas; Milind S Patole; Yogesh S Shouche
Journal:  PLoS One       Date:  2007-09-26       Impact factor: 3.240

10.  Mitochondrial complex I inhibition as a possible mechanism of chlorpyrifos induced neurotoxicity.

Authors:  Mohamed Salama; Doaa El-Morsy; Mohamed El-Gamal; Osama Shabka; Wael My Mohamed
Journal:  Ann Neurosci       Date:  2014-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.